Y-mAbs Therapeutics, Inc. (YMAB) Revenue by Year
Y-mAbs Therapeutics, Inc. generated $87.7M in revenue in fiscal year 2024. This represents an increase of 3.4% from the prior fiscal year. Over the trailing 12 months, Q3 FY2024 through Q2 FY2025, the same line adds up to $85.4M in revenue. The table below carries 8 fiscal years, from 2017 to 2024, and the quarters Y-mAbs Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
YMAB Revenue by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2024 through Q2 FY2025, summed from the four most recent quarterly filings.
YMAB Revenue by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More Y-mAbs Therapeutics, Inc. financials
Frequently Asked Questions
What was Y-mAbs Therapeutics, Inc.'s revenue in fiscal year 2024?
Y-mAbs Therapeutics, Inc. generated $87.7M in revenue in fiscal year 2024.
How fast is Y-mAbs Therapeutics, Inc.'s revenue growing?
Y-mAbs Therapeutics, Inc. (YMAB) revenue rose by 3.4% year over year, from $84.8M to $87.7M in fiscal year 2024.
What is Y-mAbs Therapeutics, Inc.'s revenue over the last twelve months?
Y-mAbs Therapeutics, Inc. (YMAB) reported $85.4M in revenue over the trailing 12 months, Q3 FY2024 through Q2 FY2025, summed from the four most recent quarterly filings.
What was Y-mAbs Therapeutics, Inc.'s revenue in the most recent quarter?
Y-mAbs Therapeutics, Inc. (YMAB) reported $19.5M in revenue in Q2 2025. This represents a decrease of 14.4% from the same quarter a year earlier.
What does revenue mean on a financial statement?
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Y-mAbs Therapeutics, Inc. (YMAB) reported on that line in every period on record.